Trade name: FluMist® Quadrivalent
Generic names: Influenza Vaccine Live, Intranasal Spray
Indication and Usage: The FDA has approved this vaccine for active immunization for the prevention of influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine. FluMist Quadrivalent is approved for use in persons 2 through 49 years of age.
Manufacturer-listed adverse reactions: FluMist® Quadrivalent can cause: Pericarditis, Exacerbation of symptoms of mitochondrial encephalomyopathy (Leigh syndrome), Nausea, Vomiting, Diarrhea, Anaphylactic reaction, Facial edema, Urticaria (hives), Guillain-Barré syndrome, Bell’s Palsy, Meningitis, Eosinophilic meningitis, Vaccine-associated encephalitis, Epistaxis (Nose bleeds), Rash. Unlike the other flu products, the Flumist contains a live, attenuated (weakened) virus. The manufacturer warns of transmission to immunocompromised contacts.
Need more info? Click the link below for a helpful infographic you can view + save on your device.
For Flumist alternatives, please visit the Flu webpage.